Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Opened, Not Controlled and Multicentric Clinical Trial of Pazopanib in Monotherapy to Determine Efficiency and Safety in Second-line of Treatment in Patients With Carcinoma of Advanced Renal Cells That Have Progressed or Have Not Tolerated the First Line of Treatment With Tyrosine Kinase Inhibitor

NCT01577784 is registered in ClinicalTrials.gov with Associació per a la Recerca Oncologica, Spain as lead sponsor.

NCT NCT01577784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Opened, Not Controlled and Multicentric Clinical Trial of Pazopanib in Monotherapy to Determine Efficiency and Safety in Second-line of Treatment in Patients With Carcinoma of Advanced Renal Cells That Have Progressed or Have Not Tolerated the First Line of Treatment With Tyrosine Kinase Inhibitor
Lead sponsor
Associació per a la Recerca Oncologica, Spain
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2012
Completion date
October 31, 2015
Enrollment
27 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma